1. Straube, A, Pfaffenrath, V, Ladwig, KH, et al. Prevalence of chronic migraine and medication overuse headache in Germany – the German DMKG headache study. Cephalalgia 2010; 30: 207–213.
Google Scholar | SAGE Journals | ISI2. Jonsson, P, Hedenrud, T, Linde, M. Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia 2011; 31: 1015–1022.
Google Scholar | SAGE Journals | ISI3. Zwart, JA, Dyb, G, Hagen, K, et al. Depression and anxiety disorders associated with headache frequency. The Nord-Trondelag Health Study. Eur J Neurol 2003; 10: 147–152.
Google Scholar | Crossref | Medline | ISI4. Jellestad, PL, Carlsen, LN, Westergaard, ML, et al. Economic benefits of treating medication-overuse headache – results from the multicenter COMOESTAS project. Cephalalgia 2019; 39: 274–285.
Google Scholar | SAGE Journals | ISI5. Global Burden of Disease (GBD) 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388: 1545–1602.
Google Scholar | Crossref | Medline6. Diener, HC, Antonaci, F, Braschinsky, M, et al. European Academy of Neurology guideline on the management of medication-overuse headache. Eur J Neurol 2020; 27:1102–1106.
Google Scholar | Crossref | Medline7. Bendtsen, L, Birk, S, Kasch, H, et al. Reference programme: Diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd edn, 2012. J Headache Pain 2012; 13: S1–S29.
Google Scholar | Crossref | Medline | ISI8. Carlsen, LN, Munksgaard, SB, Nielsen, M, et al. Comparison of 3 treatment strategies for medication overuse headache: A randomized clinical trial. JAMA Neurol 2020; 77: 1069–1078.
Google Scholar | Crossref | Medline9. Schwedt, TJ, Hentz, JG, Sahai-Srivastava, S, et al. Headache characteristics and burden from chronic migraine with medication overuse headache: Cross-sectional observations from the Medication Overuse Treatment Strategy trial. Headache 2021; 61: 351–362.
Google Scholar | Crossref | Medline10. Pijpers, JA, Kies, DA, Louter, MA, et al. Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: A double-blind randomized controlled trial. Brain 2019; 142: 1203–1214.
Google Scholar | Crossref | Medline11. Rabe, K, Pageler, L, Gaul, C, et al. Prednisone for the treatment of withdrawal headache in patients with medication overuse headache: A randomized, double-blind, placebo-controlled study. Cephalalgia 2013; 33: 202–207.
Google Scholar | SAGE Journals | ISI12. Boe, MG, Mygland, A, Salvesen, R. Prednisolone does not reduce withdrawal headache: A randomized, double-blind study. Neurology 2007; 69: 26–31.
Google Scholar | Crossref | Medline | ISI13. Tassorelli, C, Jensen, R, Allena, M, et al. A consensus protocol for the management of medication-overuse headache: Evaluation in a multicentric, multinational study. Cephalalgia 2014; 34: 645–655.
Google Scholar | SAGE Journals | ISI14. Ravishankar, K. Medication overuse headache in India. Cephalalgia 2008; 28: 1223–1226.
Google Scholar | SAGE Journals | ISI15. Fuh, JL, Wang, SJ, Lu, SR, et al. Does medication overuse headache represent a behavior of dependence? Pain 2005; 119: 49–55.
Google Scholar | Crossref | Medline | ISI16. Kanki, R, Nagaseki, Y, Sakai, F. Medication-overuse headache in Japan. Cephalalgia 2008; 28: 1227–1228.
Google Scholar | SAGE Journals | ISI17. Dong, Z, Chen, X, Steiner, TJ, et al. Medication-overuse headache in China: Clinical profile, and an evaluation of the ICHD-3 beta diagnostic criteria. Cephalalgia 2015; 35: 644–651.
Google Scholar | SAGE Journals | ISI18. Headache Classification Committee of the International Headache Society . The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38: 1–211.
Google Scholar19. Tepper, SJ, Diener, HC, Ashina, M, et al. Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trial. Neurology 2019; 92: e2309–e2320.
Google Scholar | Crossref | Medline20. Dodick, DW, Doty, EG, Aurora, SK, et al. Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine. Cephalalgia 2021; 41: 340–352.
Google Scholar | SAGE Journals | ISI21. Silberstein, SD, Cohen, JM, Seminerio, MJ, et al. The impact of fremanezumab on medication overuse in patients with chronic migraine: Subgroup analysis of the HALO CM study. J Headache Pain 2020; 21: 114.
Google Scholar | Crossref | Medline22. Chu, M-K, Im, H-J, Ju, Y-S, et al . Validity and reliability assessment of Korean Headache Impact Test-6 (HIT-6). J Korean Neurol Assoc 2009; 27: 1–6.
Google Scholar23. Lee, H-S, Chung, C-S, Song, H-J, et al. The reliability and validity of the MIDAS (Migraine Disability Assessment) questionnaire for Korean migraine sufferers. J Korean Neurol Assoc 2000; 18: 287–291.
Google Scholar24. Seo, JG, Park, SP. Validation of the Patient Health Questionnaire-9 (PHQ-9) and PHQ-2 in patients with migraine. J Headache Pain 2015; 16: 65.
Google Scholar | Crossref | Medline | ISI25. Seo, JG, Park, SP. Validation of the Generalized Anxiety Disorder-7 (GAD-7) and GAD-2 in patients with migraine. J Headache Pain 2015; 16: 97.
Google Scholar | Crossref | Medline | ISI26. Lee, YK, Nam, HS, Chuang, LH, et al. South Korean time trade-off values for EQ-5D health states: Modeling with observed values for 101 health states. Value Health 2009; 12: 1187–1193.
Google Scholar | Crossref | Medline | ISI27. Seo, JG, Park, SP. Validation of the Korean Migraine-Specific Quality of Life Questionnaire Version 2.1 in episodic and chronic migraine. J Oral Facial Pain Headache 2017; 31: 251–256.
Google Scholar | Crossref | Medline28. Lee, EH, Chung, BY, Suh, CH, et al. Korean versions of the Perceived Stress Scale (PSS-14, 10 and 4): Psychometric evaluation in patients with chronic disease. Scand J Caring Sci 2015; 29: 183–192.
Google Scholar | Crossref | Medline29. Lipton, RB, Bigal, ME, Ashina, S, et al. Cutaneous allodynia in the migraine population. Ann Neurol 2008; 63: 148–158.
Google Scholar | Crossref | Medline | ISI30. Dowson, AJ, Tepper, SJ, Baos, V, et al. Identifying patients who require a change in their current acute migraine treatment: The Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire. Curr Med Res Opin 2004; 20: 1125–1135.
Google Scholar | Crossref | Medline | ISI31. Rossi, P, Faroni, JV, Tassorelli, C, et al. Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): A prospective, randomized, open-label trial. J Headache Pain 2013; 14: 10.
Google Scholar | Crossref | Medline | ISI32. Chiang, CC, Schwedt, TJ, Wang, SJ, et al. Treatment of medication-overuse headache: A systematic review. Cephalalgia 2016; 36: 371–386.
Google Scholar | SAGE Journals | ISI33. Krymchantowski, AV, Tepper, SJ, Jevoux, C, et al. Medication-overuse headache: Differences between daily and near-daily headache patients. Brain Sci 2016; 6: 30.
Google Scholar | Crossref | Medline34. Viana, M, De Icco, R, Allena, M, et al. Clinical subtypes of medication overuse headache – findings from a large cohort. Headache 2019; 59: 1481–1491.
Google Scholar | Crossref | Medline35. Diener, HC, Holle, D, Solbach, K, et al. Medication-overuse headache: Risk factors, pathophysiology and management. Nat Rev Neurol 2016; 12: 575–583.
Google Scholar | Crossref | Medline36. Bendtsen, L, Munksgaard, S, Tassorelli, C, et al. Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project). Cephalalgia 2014; 34: 426–433.
Google Scholar | SAGE Journals | ISI37. Cho, S-J. Update of medication-overuse headache and medication-overuse. Korean J Headache 2020; 21: 48–54.
Google Scholar | Medline38. American Headache, Society. The American Headache Society position statement on integrating new migraine treatments into clinical practice. Headache 2019; 59: 1–18.
Google Scholar